biote: 3 Key Takeaways for Long-Term Investors
biote Corp. (BTMD) Q3 2026 Earnings Call Transcript
Biote Corp (BTMD) (Q3 2026) Earnings Call Highlights: Recall Recovery Lags, But Margin and ...
Biote (NASDAQ:BTMD) Q3 Profit Beat and Revenue Miss: Stabilization Hopes Drive Sharp After-Hours Rally
biote Corp. (BTMD) Tops Q3 Earnings Estimates
Biote Reports Third Quarter 2026 Financial Results
Biote Q3 2026 Earnings Call Transcript
Biote FY2026 Revenue expected to be more than $175.000M vs $180.660M Est
Biote Schedules Third Quarter 2026 Financial Results Release and Conference Call
B. Riley Securities Maintains Neutral on Biote, Lowers Price Target to $1.5
TD Cowen Maintains Buy on Biote, Lowers Price Target to $2
Biote Corp (BTMD) (Q2 2026) Earnings Call Highlights: Navigating Recall Challenges and ...
biote Corp. (BTMD) Q2 2026 Earnings Call Transcript
biote Q2 Earnings Call Highlights
Biote FY2026 Revenue expected to be more than $175.000M vs $190.807M Est
Biote Q2 EPS $(0.23) Misses $0.04 Estimate, Sales $44.232M Miss $46.148M Estimate
Biote Schedules Second Quarter 2026 Financial Results Release and Conference Call
How The Evolving Story For biote (BTMD) May Shape Future Investor Expectations
Biote Appoints Komal Bajaj, MD, MS as Chief Medical Officer
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.